KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Depreciation and Depletion (2017 - 2025)

Guardant Health's Depreciation and Depletion history spans 9 years, with the latest figure at $9.7 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 2.02% year-over-year to $9.7 million; the TTM value through Dec 2025 reached $38.1 million, down 4.99%, while the annual FY2025 figure was $38.1 million, 4.99% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $9.7 million at Guardant Health, up from $9.0 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $10.3 million in Q3 2023 and bottomed at $4.5 million in Q1 2021.
  • The 5-year median for Depreciation and Depletion is $9.6 million (2023), against an average of $8.6 million.
  • The largest annual shift saw Depreciation and Depletion surged 82.0% in 2022 before it decreased 10.89% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $5.6 million in 2021, then skyrocketed by 69.64% to $9.5 million in 2022, then rose by 7.37% to $10.2 million in 2023, then decreased by 2.94% to $9.9 million in 2024, then decreased by 2.02% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Depreciation and Depletion are $9.7 million (Q4 2025), $9.0 million (Q3 2025), and $9.6 million (Q2 2025).